|
|
|
Integrative Oncology: How it Can Enhance Cancer Care
Speaker: Gary Deng, MD, PhD, Medical College of Cornell University
12:00 PM - 1:00 PM
Host: UCI Susan Samueli Integrative Health Institute
Palmer Family Research and Conference Room or Register for Zoom link
| | | |
|
|
CRI Seminar Series
Speaker: Claus Jørgensen, PhD, Cancer Research UK Manchester Institute
11:00 AM - 12:30 PM
Dr. Jørgensen is interested in the chemical messages that are sent between cells as pancreatic cancer develops.
Sprague Hall 105
| | | |
|
|
Disparities in Health-Related Quality of Life Among Lesbian, Gay, and Bisexual Cancer Survivors: Insights from the All of Us Research Program Database
Speakers: Katie Darabos, PhD, Rutgers School of Public Health & Daniel Moretti, MSc, PRIDEnet, Stanford University School of Medicine
12:00 PM - 1:00 PM
Host: UCI Health All of Us Research Program
Register for Zoom link
| | |
Belonging, Equity and Empowerment (BEE) Scene | |
Accepting Nominations! Learning about each other cultivates an inclusive environment where everyone feels empowered to contribute and succeed. Nominate a colleague for a spotlight showcasing their unique stories beyond their roles at the CFCCC. Faculty, staff, and self-nominations are encouraged.
| |
Beyond Cancer Spotlight: Daniel Rivas
For National Cancer Survivors Month, we're spotlighting Daniel Rivas, MA, Director, Office of Community Outreach & Engagement (COE). As a gastric cancer survivor, Daniel's personal journey and community-focused mission drive his dedication to supporting others in their fight. Dive into his story to learn more about his passions, motivations, and that one time he performed with Michael Jackson!
| |
|
Eleven faculty members completed the Cancer Clinical Trial Bootcamp this month, dedicating 16 weeks to learning how to design and write investigator-initiated cancer clinical trials. A big thank you to our CFCCC collaborators for their invaluable mentorship of these cancer researchers. The next Cancer Clinical Trial Bootcamp will commence in early 2025. For questions, please email Kimberly Castellanos at kecastel@hs.uci.edu. (Pictured left to right: Drs. Michael Hicks, Warren Chow, Yoon Choi, Edward Nelson, Amy Li, Alyssa Bujnak, Pournima Navalkele, Misako Nagasaka, Sami Dwabe, and Farshid Dayyani) | |
|
UCI Anti-Cancer Challenge Raises $1 Million in 2023 to fund 23 Research Grants
Through the unwavering support of dedicated participants, donors and supporters who collectively raised $1 million in 2023, the UCI Anti-Cancer Challenge has awarded grants to 23 pilot projects and early phase clinical trials, reaching a remarkable milestone of 123 funded projects since 2017. These projects are poised to revolutionize the future of cancer diagnosis, treatment and cures. Learn more about the funded research projects.
| |
|
Registration is Now Open for the CFCCC Scientific Retreat
Join us for this year's one-day Scientific Retreat on Friday, November 8, 2024 at The Waterfront Beach Resort, a Hilton Hotel, Huntington Beach. Register Here.
Poster Session: faculty, please encourage your pre and postdoctoral trainees to submit an abstract for the poster session! The top three posters will receive an award.
| |
|
Entering Mentoring Training Interest Form
The CFCCC Cancer Research Training & Education Coordination (CRTEC) team are considering bringing the Entering Mentoring curriculum, developed by the Center for Improvement of Mentored Experiences in Research (CIMER), to our institution. This program aims to enhance mentors' skills for productive, culturally responsive mentoring relationships, benefiting both mentors and research trainees.
To help us decide whether to offer this training at the CFCCC, please complete the interest form by June 25. For questions, please email Kimberly Castellanos at kecastel@hs.uci.edu.
| |
|
2024 UCaTS Call for D-PDTC Pilot Studies
The University of California and UT Southwestern Disparities PDX Development and Trial Center (UCaTS) comprised of UC Davis (lead), UCSF, UCI, UCLA, UCSD and UT Southwestern is accepting applications to contribute to the achievement of the UCaTS’ overall objectives of developing PDX trial strategies for preclinical testing of single agents and drug combinations, with a focus on the predominant racial/ethnic minority populations residing in California and Texas, namely, Hispanic/Latino Americans [HLAs], Asian Americans/Native Hawaiians/Pacific Islanders [AANHPIs], and African Americans [AAs]. The focus will be on gastric and lung cancers that disproportionately affect minority populations using FDA approved therapeutic agents. This call is for pilot study applications of budgets of up to $50,000 direct costs (plus F&A) with a 09/01/2024 start date and that must be expended by 08/31/2025. Learn more here.
| |
|
Congratulations to Awosanya Oluwaseun (Seun), MDY1, on the American Society of Hematology Minority Medical Student Award!
This is a prestigious national award to promote research and career advancement. Seun will be mentored by Dr. Kalpna Gupta (SPT) and Dr. Linda Burns, previous President of ASH. Additionally, Dr. Zahra Pakbaz, Dr. Wei Ling Lau from the Department of Medicine and Dr. Srila Gopal, UCSD will be her co-mentors.
| |
|
Experimental Tissue Shared Resource (ETR) Offers Custom Tissue Microarray and Brightfield Whole Slides Scanning
The ETR is excited to discuss your project’s study design and tissue needs. We can now create custom tissue microarrays (TMA) with tissue you provide or human tissue remnants and scan whole histology slides at 40X. Selection of optimal representative tissue regions can be performed by our pathologist.
We can provide histology support for special transcriptomics platforms supported by GTH Share Resource
Questions? Contact Delia Tifrea, ETR Core Manager, 714-872-1093.
| |
|
The Biobehavioral Shared Resource (BBSR) Consultation & Comprehensive Project Request is Live
The BBSR is excited to discuss your project’s study design and needs, as well as see how our new menu of services can best support your project goals.
During our “Consultation Meeting” we’ll learn more about your project and how the BBSR can support your team. Ready to schedule? Complete the "Consultation Request" on iLab.
Questions? Contact Jose Lechuga, BBSR Core Manager.
| |
|
Biostatistics Shared Resource - In-person Walk-in or Zoom Consultations Available
Informal statistical in-person walk-in or via Zoom consultations are available to discuss your study design and statistical needs.
With Wen-pin Chen, MS, Senior Statistician & Manager for BSR:
With Thomas H. Taylor, PhD, Principal Statistician for BSR:
-
Every Wednesday from 2:00 - 3:00 PM via Zoom | No pre-booking necessary, drop in here
With Dabao Zhang, PhD, Principal Statistician for BSR:
-
Every Tuesday from 1:00 - 2:00 PM via Zoom | Pre-booking is encouraged although it is not necessary (email Dr. Zhang), drop in here
| |
|
For a curated list of internal, federal and foundation funding opportunities, please refer to CFCCC's Funding Opportunities webpage. Highlighted funding opportunities are listed below.
UCI & UC FUNDING OPPORTUNITIES
UCI CFCCC: A1 Bridge
Up to $20k in bridge funding to investigators who have received scores on NIH grant applications (i.e., not triaged) that have missed the funding pay line and will be resubmitted.
Applications: Due on a rolling basis
Learn More and Apply >>
| |
|
FOUNDATION FUNDING OPPORTUNITIES
St. Baldrick's Foundation Fall Grant Cycle
Focus area: childhood cancers
$25k - $50k
Letter of Intent: July 8, 2024
Learn More and Apply >>
(NEW) A Breath of Hope Lung Foundation - Peg's Fight for Life Award
Focus area: lung cancer
$150k
Letter of Intent: July 13, 2024
Learn More and Apply >>
| |
|
OTHER NON-FEDERAL FUNDING OPPORTUNITIES
California Breast Cancer Research Program (CBCRP)
Focus area: artificial light pollution and breast cancer
$150k / 6 months
Applications: August 8, 2024
Learn More and Apply >>
| |
|
FEDERAL FUNDING OPPORTUNITIES
NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12 Clinical Trial Optional)
Applications: June 18, 2024
Learn More and Apply >>
(NEW) NIH Director's Early Independence Award
Focus area: junior investigators who wish to pursue independent research soon after completion of their terminal doctoral degree or post-graduate clinical training
$250k per year for up to 5 years
Preliminary Application: June 24, 2024
Learn More and Apply >>
(NEW) NCI Addressing Barriers to Healthcare Transitions for Survivors of Childhood and Adolescent Cancers (R01 Clinical Trial Optional)
Focus area: NCI is particularly interested in applications that address barriers to care that contribute to disparities in health outcomes for childhood cancer survivors, and/or that focus on high-risk groups such as the uninsured/under-insured. Studies should focus on issues specific to childhood cancer survivors rather than general care coordination issues.
$499k per year for up to 5 years
Preliminary Application: October 11, 2024
Learn More and Apply >>
Congressionally Directed Medical Research Programs (CDMRP)
FY24 Breast Cancer Research Program (BCRP) - next deadline August 6, 2024
(NEW) FY24 Bone Marrow Failure Research Program (BMFRP) - next deadline July 17, 2024
FY24 Lung Cancer Research Program (LCRP) - next deadline August 7, 2024
FY24 Ovarian Cancer Research Program (OCRP) - next deadline June 24, 2024
FY24 Pancreatic Cancer Research Program (PCARP) - next deadline June 28, 2024
(NEW) FY24 Peer-Reviewed Cancer Research Program (PRCRP) - next deadline June 21, 2024
(NEW) FY24 Prostate Cancer Research Program (PCRP) - next deadline June 21, 2024
FY24 Melanoma Research Program (MRP) - next deadline July 29, 2024
Kidney Cancer Research Program | Pre-Announcement (multiple awards)
Learn More >>
| | |
|
|
'Cutting the cable' between CD8+ T and T regulatory cells enhances checkpoint immunotherapy
“Our latest research reveals that CD8+ T cells, activated by PD-1 blockade to target melanoma, also interact with T regulatory cells, which subsequently dampen the immune response against the tumor,” said corresponding author Francesco Marangoni, UC Irvine assistant professor of physiology & biophysics.
Read More >>
| | |
|
|
UC Irvine study reveals circadian clock can be leveraged to enhance cancer immunotherapy
A multidisciplinary research team at the University of California, Irvine has revealed that the circadian clock – the biological pacemaker that governs daily rhythms in physiological processes, including immune functions – can be leveraged to enhance the efficacy of checkpoint inhibitor cancer therapy. Checkpoint inhibitors block different proteins from binding to tumor cells, allowing the immune system’s T cells to kill the tumor.
Read More >>
| | |
|
|
UCI Anti-Cancer Challenge Awards $1 million for promising cancer research
The UCI Anti-Cancer Challenge has awarded $1 million raised in 2023 to fund a new round of transformative research projects at the UCI Health Chao Family Comprehensive Cancer Center and its pediatric cancer affiliate, Children's Hospital of Orange County (CHOC).
Read More >>
| | |
|
|
A literal gut check
A healthy microbiome in your digestive tract can help stave off heart disease, cancer and other ailments, says Katrine Whiteson, a Chancellor's Fellow and associate professor of molecular biology and biochemistry at UC Irvine.
Read More >>
| | | | |
